CardiAQ Uses Early-Feasibility IDE Paradigm To Bring Trans-Mitral Valve Device To U.S. Clinicians
This article was originally published in The Gray Sheet
Executive Summary
The California startup was able to leverage a new FDA process for early-feasibility device trials to launch a small U.S. study of its transfemoral and transapical transcatheter mitral valve implantation systems.